26 research outputs found
Chemical, Structural, and Morphological Changes of a MoVTeNb Catalyst during Oxidative Dehydrogenation of Ethane
MoVTeNb mixed oxide, a highly active and
selective catalyst for the oxidative dehydrogenation of ethane to
produce ethylene, exhibits the so-called M1 and M2 crystalline
phases. The thermal stability of the MoVTeNb catalytic system
was assessed under varying reaction conditions; to this end, the
catalyst was exposed to several reaction temperatures spanning
from 440 to 550 °C. Both the pristine and spent materials were
analyzed by several characterization techniques. The catalyst
was stable below 500 °C; a reaction temperature of âĽ500 °C
brings about the removal of tellurium from the intercalated
framework channels of the M1 crystalline phase. Rietveld
refinement of X-ray diffraction patterns and microscopy results showed that the tellurium loss causes the progressive partial
destruction of the M1 phase, thus decreasing the number of active sites and forming a MoO2 crystalline phase, which is inactive
for this reaction. Raman spectroscopy confirmed the MoO2 phase development as a function of reaction temperature. From highresolution
transmission electron microscopy and energy-dispersive X-ray spectroscopy analyses it was noticed that tellurium
departure occurs preferentially from the end sides of the needlelike M1 crystals, across the [001] plane. Detailed analysis of a
solid deposited at the reactor outlet showrf that it consisted mainly of metallic tellurium, suggesting that the tellurium
detachment occurs via reduction of Te4+ to Te0 due to a combination of reaction temperature and feed composition. Thus, in
order to sustain the catalytic performance exhibited by MoVTeNb mixed oxide, hot spots along the reactor bed should be
avoided or controlled, maintaining the catalytic bed temperature below 500 °C.This work was financially supported by the Instituto Mexicano del Petroleo.Valente, JS.; Armendariz-Herrera, H.; Quintana-Solorzano, R.; Del Angel, P.; Nava, N.; Masso RamĂrez, A.; LĂłpez Nieto, JM. (2014). Chemical, Structural, and Morphological Changes of a MoVTeNb Catalyst during Oxidative Dehydrogenation of Ethane. ACS Catalysis. 4:1292-1301. doi:10.1021/cs500143jS12921301
Abrolhos Bank Reef Health Evaluated by Means of Water Quality, Microbial Diversity, Benthic Cover, and Fish Biomass Data
The health of the coral reefs of the Abrolhos Bank (southwestern Atlantic) was characterized with a holistic approach using measurements of four ecosystem components: (i) inorganic and organic nutrient concentrations, [1] fish biomass, [1] macroalgal and coral cover and (iv) microbial community composition and abundance. The possible benefits of protection from fishing were particularly evaluated by comparing sites with varying levels of protection. Two reefs within the well-enforced no-take area of the National Marine Park of Abrolhos (Parcel dos Abrolhos and California) were compared with two unprotected coastal reefs (SebastiĂŁo Gomes and Pedra de Leste) and one legally protected but poorly enforced coastal reef (the âpaper parkâ of Timbebas Reef). The fish biomass was lower and the fleshy macroalgal cover was higher in the unprotected reefs compared with the protected areas. The unprotected and protected reefs had similar seawater chemistry. Lower vibrio CFU counts were observed in the fully protected area of California Reef. Metagenome analysis showed that the unprotected reefs had a higher abundance of archaeal and viral sequences and more bacterial pathogens, while the protected reefs had a higher abundance of genes related to photosynthesis. Similar to other reef systems in the world, there was evidence that reductions in the biomass of herbivorous fishes and the consequent increase in macroalgal cover in the Abrolhos Bank may be affecting microbial diversity and abundance. Through the integration of different types of ecological data, the present study showed that protection from fishing may lead to greater reef health. The data presented herein suggest that protected coral reefs have higher microbial diversity, with the most degraded reef (SebastiĂŁo Gomes) showing a marked reduction in microbial species richness. It is concluded that ecological conditions in unprotected reefs may promote the growth and rapid evolution of opportunistic microbial pathogens
Massive X-ray screening reveals two allosteric drug binding sites of SARS-CoV-2 main protease
The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous health problems and economical challenges for mankind. To date, no effective drug is available to directly treat the disease and prevent virus spreading. In a search for a drug against COVID-19, we have performed a massive X-ray crystallographic screen of repurposing drug libraries containing 5953 individual compounds against the SARS-CoV-2 main protease (Mpro), which is a potent drug target as it is essential for the virus replication. In contrast to commonly applied X-ray fragment screening experiments with molecules of low complexity, our screen tested already approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds binding to Mpro. In subsequent cell-based viral reduction assays, one peptidomimetic and five non-peptidic compounds showed antiviral activity at non-toxic concentrations. Interestingly, two compounds bind outside the active site to the native dimer interface in close proximity to the S1 binding pocket. Another compound binds in a cleft between the catalytic and dimerization domain of Mpro. Neither binding site is related to the enzymatic active site and both represent attractive targets for drug development against SARS-CoV-2. This X-ray screening approach thus has the potential to help deliver an approved drug on an accelerated time-scale for this and future pandemics
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous human suffering. To date, no effective drug is available to directly treat the disease. In a search for a drug against COVID-19, we have performed a high-throughput X-ray crystallographic screen of two repurposing drug libraries against the SARS-CoV-2 main protease (M^(pro)), which is essential for viral replication. In contrast to commonly applied X-ray fragment screening experiments with molecules of low complexity, our screen tested already approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds that bind to M^(pro). In subsequent cell-based viral reduction assays, one peptidomimetic and six non-peptidic compounds showed antiviral activity at non-toxic concentrations. We identified two allosteric binding sites representing attractive targets for drug development against SARS-CoV-2
Composition, uses, provenance and stability of rocks and ancient mortars in a Theban Tomb in Luxor (Egypt)
Functionalized powdered activated carbon electrospun nanofiber membranes for adsorption of micropollutants
Genomes of surface isolates of Alteromonas macleodii: the life of a widespread marine opportunistic copiotroph
Development of a nanocomposite ultrafiltration membrane based on polyphenylsulfone blended with graphene oxide
Genomic and metabolic diversity of marine group I thaumarchaeota in the mesopelagic of two subtropical gyres
Swan BK, Chaffin MD, Martinez-Garcia M, et al. Genomic and metabolic diversity of marine group I thaumarchaeota in the mesopelagic of two subtropical gyres. PloS one. 2014;9(4): e95380.Marine Group I (MGI) Thaumarchaeota are one of the most abundant and cosmopolitan chemoautotrophs within the global dark ocean. To date, no representatives of this archaeal group retrieved from the dark ocean have been successfully cultured. We used single cell genomics to investigate the genomic and metabolic diversity of thaumarchaea within the mesopelagic of the subtropical North Pacific and South Atlantic Ocean. Phylogenetic and metagenomic recruitment analysis revealed that MGI single amplified genomes (SAGs) are genetically and biogeographically distinct from existing thaumarchaea cultures obtained from surface waters. Confirming prior studies, we found genes encoding proteins for aerobic ammonia oxidation and the hydrolysis of urea, which may be used for energy production, as well as genes involved in 3-hydroxypropionate/4-hydroxybutyrate and oxidative tricarboxylic acid pathways. A large proportion of protein sequences identified in MGI SAGs were absent in the marine cultures Cenarchaeum symbiosum and Nitrosopumilus maritimus, thus expanding the predicted protein space for this archaeal group. Identifiable genes located on genomic islands with low metagenome recruitment capacity were enriched in cellular defense functions, likely in response to viral infections or grazing. We show that MGI Thaumarchaeota in the dark ocean may have more flexibility in potential energy sources and adaptations to biotic interactions than the existing, surface-ocean cultures